PLATINUM-SENSITIVE OVARIAN CANCER
Clinical trials for PLATINUM-SENSITIVE OVARIAN CANCER explained in plain language.
Never miss a new study
Get alerted when new PLATINUM-SENSITIVE OVARIAN CANCER trials appear
Sign up with your email to follow new studies for PLATINUM-SENSITIVE OVARIAN CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for ovarian cancer: drug combo aims to extend remission
Disease control Recruiting nowThis study tests whether adding the experimental drug Rina-S to standard therapy helps keep ovarian cancer from growing back in people whose cancer had previously responded to platinum chemotherapy. About 528 adults with recurrent platinum-sensitive ovarian cancer will receive ei…
Matched conditions: PLATINUM-SENSITIVE OVARIAN CANCER
Phase: PHASE3 • Sponsor: Genmab • Aim: Disease control
Last updated May 26, 2026 11:29 UTC
-
New hope for ovarian cancer: experimental drug IMGN151 enters phase 2 trial
Disease control Recruiting nowThis study tests an experimental drug called IMGN151 for people with gynecologic cancers, including ovarian cancer. The drug is given alone or with other cancer treatments to see if it is safe and works. About 377 adults will take part at sites worldwide. The goal is to find bett…
Matched conditions: PLATINUM-SENSITIVE OVARIAN CANCER
Phase: PHASE2 • Sponsor: AbbVie • Aim: Disease control
Last updated May 26, 2026 11:28 UTC